LATEST News:
Functional Mushrooms – a naturally occurring compound that has shown significant promise in clinical studies for treating mental health conditions such as depression, anxiety, PTSD, and addiction.
SYMBOL: OTCQB: FUNI
- Outstanding Shares: 126,046,825 (as of 12/04/2024)
- Float: 66,572,365 (as of 8/26/2024)
hyphalabs.com
Unlock the Future of Health and Wellness with Hypha Labs’ Functional Mushroom Innovations
Revolutionizing Health with Functional Mushrooms: The Hyphalabs Promise
In a world increasingly turning to natural solutions for health and wellness, Hypha Labs is at the forefront of innovation. With its state-of-the-art bioreactor technology, Hypha Labs is redefining how we cultivate and consume therapeutic mushrooms. These functional fungi, known for their numerous health benefits, can now be grown easily at home or in small-scale production facilities, providing a new level of accessibility and convenience for those seeking natural remedies.
Cutting-Edge Bioreactor Technology for High-Quality Mushroom Cultivation
Hyphalabs’ bioreactor technology isn’t just advanced—it’s transformative. Traditional mushroom cultivation can be time-consuming and complex, requiring specialized conditions and expertise. Hyphalabs’ technology simplifies this process, allowing even novice growers to produce high-quality mushrooms with minimal effort. This technology harnesses precise environmental controls and nutrient optimization, ensuring that each batch of mushrooms is consistent, potent, and rich in therapeutic compounds.
Day by day more is being discovered about the mental and physical benefits that mushrooms bring us. Our purpose is to make getting the benefits of functional mushrooms to as many people as possible with measurable dosages, and reduced side effects, and all within the comfort of peoples homes.
Why Invest in HyphaLabs?
Hyphalabs isn’t just a company—it’s a vision for the future of health and wellness. By investing in Hypha Labs, you are supporting a pioneering approach to biotechnology that leverages nature’s most potent resources for human benefit. Whether you are a health enthusiast, a small-scale producer, or an investor, Hypha Labs offers a unique opportunity to be part of a rapidly growing industry with the potential to reshape how we think about and approach wellness.
Join the movement. Invest in the future of health—invest in Hyphalabs >>
Hyphalabs Investor Presentation
Advancing Mental and Physical Health: The HyphaLabs Mission
At the core of HyphaLabs is a commitment to enhancing both mental and physical health.
The company’s dedicated team of industry veterans brings together expertise from biotechnology, health sciences, and agriculture, driving innovation in the functional mushroom space. Their goal is not only to provide top-quality products but also to empower people with the tools and knowledge they need to support their well-being naturally.
Bringing Natural Wellness Closer to Home
With Hyphalabs, cultivating therapeutic mushrooms no longer requires large-scale agricultural setups or expensive equipment. Individuals can grow their own functional mushrooms in the comfort of their homes, making it easier than ever to integrate these powerful natural remedies into their daily lives. From boosting mental clarity and focus to supporting the immune system, functional mushrooms like Lion’s Mane, Reishi, and Cordyceps have a myriad of health benefits that are now within reach.
Meet the Leadership Team
A. STONE DOUGLASS
CEO/CFO
Mr. Douglass is currently the Chairman and CEO of GeoSolar Technologies, Inc. He is also the Chairman and Sealand Natural Resources, Inc., a producer of birch water and other alternative beverages. He was the CEO of over 25 private and public companies, including Spy Optics, RedEnvelope, Vison America, and Piper Aircraft. He graduated with a degree in Business from Fairleigh Dickinson University in 1970.
JOHN FRAILEY
Chief Technical Director
John Frailey’s rich professional background spans both large Fortune 100 companies and startups, providing a comprehensive perspective on innovation and scalability in technical endeavors. These achievements underscore John Frailey’s commitment to driving impactful change through technological innovation and position him as an invaluable asset in the pursuit of pioneering smart connected bioreactor solutions in the biotech startup realm.
DENNIS HARTMANN
Chief Legal Officer
Dennis Hartmann is a graduate of the University Of Texas School Of Law (Austin Texas) and was a member of the Texas Law Review. His primary focus has been complex business litigation in the areas of real estate, fraud, breach of fiduciary duty, entertainment, employment, intellectual property, partnership dissolution, pursuing fraudulent conveyances and breaking offshore trusts to dismantle vehicles with no purpose other than to hide assets.
CRAIG ELLINS
Chief Science Officer
Mr. Craig Ellins is renowned for business start-ups in emerging technologies and industries. From pioneering one of the first 24-hour shopping networks to developing one of the internet’s first streaming video technologies, Mr. Ellins has spent more than 30 years creating businesses with a vision toward the future. He most recently served as founder and CEO of One World Pharma, Inc., where he built one of the largest hemp growing facilities based in Columbia, South America.
Recent News
- Hypha Laboratories Announces Completion of Phase 1 of Its State-of-the-Art Facility and Arrival of V5 Working MicroPearlsTM Prototypes – November 18, 2024
- Hypha Laboratories Establishes Scientific and Cultural Advisory Board, Adds William Padilla-Brown – October 15, 2024
- Hypha Laboratories Reveals New Patent Applications for Novel A.I. Driven In-Home Mycelium Production – October 7, 2024
- Hypha Labs, Inc. Reveals First Functional Mushroom Ingredient Array for Home and Commercial Production – September 30, 2024
- Functional Mushroom Company Hypha Labs Retains Emerging Markets Consulting LLC for Investor Relations Advisory Services – Press Release | September 26, 2024
- Hypha Labs, Inc. Releases Investor Presentation – Press Release | 09/23/2024
- Hypha Labs, Inc. Uplists to the OTCQB – Press Release | September 16, 2024
- OTC Markets Group Welcomes New OTCQB Companies – September 16, 2024
- Hypha Labs’ Revolutionary Psilocybin Bioreactor Nominated for Best New Product of 2024 by Santa Monica Daily Press – Press Release | August 20, 2024
- Digipath Name and Symbol Change Approved, Company Begins Trading as Hypha Labs, Inc. (FUNI)Press Release | August 13, 2024
- Hypha Labs’ Revolutionary Psilocybin Bioreactor Nominated for Best New Product of 2024 by Santa Monica Daily – Press Press Release | July 31, 2024
- CORRECTION: Hypha Laboratories Reveals New Patent Applications for Novel Artificial Intelligence (A.I.) Driven In-Home Mycelium Production – Press Release | July 20, 2024
- CORRECTION: Hypha Laboratories Retains Integrity Media for Investor Relations and Corporate Communications – Press Release | 07/20/2024
- CORRECTION: Hypha Laboratories Reveals New Patent Applications for Novel Artificial Intelligence (A.I.) Driven In-Home Mycelium Production – Press Release | July 19, 2024
Emerging Markets Reports
Must Read OTC Markets/SEC policy on stock promotion and investor protection
Disclaimer
EMC has been paid $50,000 by Hyphalabs Inc. and will receive an additional $50,000 in 15 days. | Please read our full disclaimer
By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Stay connected to EMC and our exclusive news through our social channels:
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.